Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Neoplasms | 24 | 2013 | 436 | 1.690 |
Why?
|
Lung | 14 | 2011 | 606 | 0.830 |
Why?
|
Lung Diseases | 6 | 2016 | 126 | 0.800 |
Why?
|
Adenocarcinoma | 11 | 2012 | 329 | 0.760 |
Why?
|
Mesothelioma | 7 | 2012 | 25 | 0.650 |
Why?
|
Bronchioles | 1 | 2015 | 2 | 0.580 |
Why?
|
Lung Diseases, Interstitial | 1 | 2015 | 32 | 0.550 |
Why?
|
Precancerous Conditions | 4 | 2003 | 68 | 0.550 |
Why?
|
Adenoma | 2 | 2013 | 54 | 0.530 |
Why?
|
Bronchi | 4 | 2006 | 66 | 0.510 |
Why?
|
Biomarkers, Tumor | 7 | 2013 | 423 | 0.510 |
Why?
|
Pathology, Surgical | 1 | 2013 | 11 | 0.500 |
Why?
|
Carcinoid Tumor | 2 | 2011 | 15 | 0.480 |
Why?
|
Alveolitis, Extrinsic Allergic | 2 | 2011 | 6 | 0.450 |
Why?
|
Schools, Medical | 1 | 2013 | 136 | 0.450 |
Why?
|
Diagnosis, Differential | 11 | 2013 | 750 | 0.450 |
Why?
|
Prototheca | 1 | 2011 | 1 | 0.440 |
Why?
|
Eye Infections | 1 | 2011 | 1 | 0.440 |
Why?
|
Keratoplasty, Penetrating | 1 | 2011 | 1 | 0.440 |
Why?
|
Fuchs' Endothelial Dystrophy | 1 | 2011 | 3 | 0.440 |
Why?
|
Cough | 2 | 2006 | 160 | 0.430 |
Why?
|
Pleural Neoplasms | 6 | 2012 | 16 | 0.430 |
Why?
|
Faculty, Medical | 1 | 2013 | 175 | 0.420 |
Why?
|
Surgical Wound Infection | 1 | 2011 | 74 | 0.420 |
Why?
|
Neuroendocrine Tumors | 1 | 2011 | 22 | 0.420 |
Why?
|
Histiocytosis, Langerhans-Cell | 3 | 2016 | 16 | 0.380 |
Why?
|
Pleura | 3 | 2011 | 10 | 0.330 |
Why?
|
Humans | 53 | 2016 | 49600 | 0.330 |
Why?
|
Arteriovenous Malformations | 1 | 2007 | 21 | 0.320 |
Why?
|
Eosinophilia | 1 | 2007 | 23 | 0.320 |
Why?
|
Eosinophils | 1 | 2007 | 42 | 0.320 |
Why?
|
Pneumothorax | 1 | 2007 | 31 | 0.320 |
Why?
|
Pulmonary Artery | 1 | 2007 | 68 | 0.310 |
Why?
|
Pulmonary Alveoli | 3 | 1997 | 36 | 0.310 |
Why?
|
Diagnostic Errors | 1 | 2007 | 85 | 0.310 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 4 | 1997 | 103 | 0.300 |
Why?
|
Immunohistochemistry | 9 | 2016 | 811 | 0.280 |
Why?
|
Neoplasm Proteins | 3 | 2007 | 256 | 0.280 |
Why?
|
Bronchoscopy | 3 | 2014 | 43 | 0.280 |
Why?
|
Chondromatosis, Synovial | 1 | 2004 | 2 | 0.270 |
Why?
|
Knee | 1 | 2004 | 21 | 0.270 |
Why?
|
Transforming Growth Factor alpha | 1 | 2004 | 12 | 0.260 |
Why?
|
Carcinoma, Small Cell | 5 | 2011 | 16 | 0.250 |
Why?
|
Epithelium | 5 | 2011 | 97 | 0.250 |
Why?
|
ErbB Receptors | 1 | 2004 | 98 | 0.250 |
Why?
|
Male | 28 | 2016 | 23124 | 0.240 |
Why?
|
Adenocarcinoma, Bronchiolo-Alveolar | 3 | 2003 | 5 | 0.240 |
Why?
|
Middle Aged | 23 | 2016 | 13449 | 0.230 |
Why?
|
Hyperplasia | 7 | 2011 | 82 | 0.220 |
Why?
|
Biopsy | 5 | 1999 | 326 | 0.210 |
Why?
|
Adenomatosis, Pulmonary | 1 | 2001 | 1 | 0.210 |
Why?
|
Fibrosis | 3 | 2015 | 97 | 0.210 |
Why?
|
RNA-Binding Proteins | 3 | 2011 | 364 | 0.210 |
Why?
|
Reflex | 1 | 2000 | 25 | 0.200 |
Why?
|
Peritoneal Neoplasms | 2 | 2011 | 19 | 0.190 |
Why?
|
Female | 30 | 2016 | 26316 | 0.190 |
Why?
|
Gastroesophageal Reflux | 1 | 2000 | 60 | 0.190 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 1998 | 11 | 0.180 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 1998 | 12 | 0.180 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1998 | 47 | 0.180 |
Why?
|
Prognosis | 9 | 2006 | 1250 | 0.160 |
Why?
|
Cathepsin B | 1 | 1997 | 13 | 0.160 |
Why?
|
Zeolites | 1 | 1997 | 2 | 0.160 |
Why?
|
Laminin | 1 | 1997 | 74 | 0.160 |
Why?
|
Pneumocystis | 1 | 1996 | 3 | 0.160 |
Why?
|
Pneumonia, Pneumocystis | 1 | 1996 | 14 | 0.150 |
Why?
|
Benzenesulfonates | 1 | 1996 | 15 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 1996 | 84 | 0.150 |
Why?
|
Lymphatic Diseases | 1 | 1995 | 11 | 0.150 |
Why?
|
Mediastinal Diseases | 1 | 1995 | 12 | 0.150 |
Why?
|
Aged | 15 | 2016 | 10872 | 0.140 |
Why?
|
Carcinoma, Squamous Cell | 5 | 2011 | 141 | 0.140 |
Why?
|
Fluorescent Dyes | 1 | 1996 | 186 | 0.130 |
Why?
|
Inflammation | 4 | 2015 | 978 | 0.130 |
Why?
|
Glass | 1 | 1994 | 21 | 0.130 |
Why?
|
MAP Kinase Signaling System | 1 | 2016 | 190 | 0.130 |
Why?
|
Adult | 15 | 2016 | 13326 | 0.130 |
Why?
|
Neoplasm Staging | 8 | 1997 | 372 | 0.130 |
Why?
|
Herpes Simplex | 1 | 2014 | 32 | 0.130 |
Why?
|
Neoplasms, Multiple Primary | 1 | 1993 | 28 | 0.120 |
Why?
|
Aged, 80 and over | 7 | 2007 | 4222 | 0.120 |
Why?
|
Genital Neoplasms, Female | 1 | 1993 | 24 | 0.120 |
Why?
|
Adolescent | 7 | 2016 | 5317 | 0.120 |
Why?
|
Thoracotomy | 1 | 2013 | 30 | 0.120 |
Why?
|
Bronchitis | 2 | 2006 | 23 | 0.120 |
Why?
|
Carcinoma | 1 | 1993 | 112 | 0.120 |
Why?
|
Smoking | 4 | 2016 | 741 | 0.110 |
Why?
|
Carcinoma in Situ | 2 | 2006 | 33 | 0.110 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2011 | 11 | 0.110 |
Why?
|
Visual Acuity | 1 | 2011 | 78 | 0.110 |
Why?
|
Antifungal Agents | 1 | 2011 | 96 | 0.100 |
Why?
|
Reoperation | 1 | 2011 | 177 | 0.100 |
Why?
|
Pneumonia, Viral | 1 | 2014 | 186 | 0.100 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2006 | 151 | 0.100 |
Why?
|
Ethanolamines | 1 | 2009 | 20 | 0.100 |
Why?
|
Respiratory Syncytial Virus Vaccines | 1 | 2009 | 18 | 0.090 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2009 | 29 | 0.090 |
Why?
|
Viral Fusion Proteins | 1 | 2009 | 69 | 0.090 |
Why?
|
Newcastle disease virus | 1 | 2009 | 83 | 0.090 |
Why?
|
Virion | 1 | 2009 | 113 | 0.090 |
Why?
|
Disease Models, Animal | 3 | 2009 | 1781 | 0.090 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2007 | 281 | 0.080 |
Why?
|
Pneumonia | 2 | 2003 | 233 | 0.080 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2007 | 13 | 0.080 |
Why?
|
Carcinoma, Endometrioid | 1 | 2007 | 18 | 0.080 |
Why?
|
Child | 4 | 2011 | 3783 | 0.080 |
Why?
|
Churg-Strauss Syndrome | 1 | 2007 | 11 | 0.080 |
Why?
|
Antibodies, Viral | 1 | 2009 | 319 | 0.080 |
Why?
|
Young Adult | 2 | 2016 | 3698 | 0.080 |
Why?
|
Massachusetts | 1 | 2013 | 2017 | 0.080 |
Why?
|
Endometrial Neoplasms | 1 | 2007 | 47 | 0.080 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2006 | 50 | 0.080 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2006 | 14 | 0.080 |
Why?
|
HIV Infections | 1 | 1993 | 898 | 0.070 |
Why?
|
Anti-Bacterial Agents | 1 | 2011 | 602 | 0.070 |
Why?
|
Calcium | 1 | 2009 | 518 | 0.070 |
Why?
|
Rats, Inbred F344 | 2 | 1997 | 55 | 0.070 |
Why?
|
Prospective Studies | 2 | 2006 | 2520 | 0.070 |
Why?
|
Foreign-Body Reaction | 2 | 1997 | 14 | 0.070 |
Why?
|
Immunoenzyme Techniques | 3 | 2006 | 99 | 0.070 |
Why?
|
Teratoma | 1 | 2005 | 12 | 0.070 |
Why?
|
DNA, Neoplasm | 2 | 2003 | 47 | 0.070 |
Why?
|
Osteochondroma | 1 | 2004 | 3 | 0.070 |
Why?
|
Breast Neoplasms | 1 | 1993 | 1036 | 0.070 |
Why?
|
Rats | 3 | 1998 | 1680 | 0.060 |
Why?
|
Animals | 8 | 2009 | 17698 | 0.060 |
Why?
|
Mycobacterium avium Complex | 1 | 2003 | 3 | 0.060 |
Why?
|
Mycobacterium avium-intracellulare Infection | 1 | 2003 | 8 | 0.060 |
Why?
|
Child, Preschool | 4 | 2005 | 1706 | 0.060 |
Why?
|
Respiratory Tract Infections | 1 | 2003 | 68 | 0.060 |
Why?
|
Chronic Disease | 1 | 2006 | 671 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 2 | 2004 | 1376 | 0.060 |
Why?
|
Immunity | 1 | 2003 | 95 | 0.060 |
Why?
|
Viruses | 1 | 2003 | 80 | 0.060 |
Why?
|
Biomarkers | 1 | 2007 | 1002 | 0.060 |
Why?
|
Cell Division | 1 | 2004 | 398 | 0.060 |
Why?
|
Virus Diseases | 1 | 2003 | 110 | 0.060 |
Why?
|
Kidney Neoplasms | 1 | 2005 | 175 | 0.060 |
Why?
|
Asthma | 1 | 2006 | 369 | 0.060 |
Why?
|
Severity of Illness Index | 1 | 2006 | 1142 | 0.060 |
Why?
|
Retrospective Studies | 3 | 1997 | 4513 | 0.050 |
Why?
|
Textile Industry | 1 | 1999 | 5 | 0.050 |
Why?
|
Bronchiolitis Obliterans | 1 | 1999 | 7 | 0.050 |
Why?
|
Esophagus | 1 | 2000 | 41 | 0.050 |
Why?
|
Pulmonary Fibrosis | 2 | 1997 | 24 | 0.050 |
Why?
|
Struma Ovarii | 1 | 1999 | 3 | 0.050 |
Why?
|
Thyrotoxicosis | 1 | 1999 | 7 | 0.050 |
Why?
|
Cross-Sectional Studies | 1 | 2006 | 2121 | 0.050 |
Why?
|
Polymerase Chain Reaction | 2 | 2016 | 456 | 0.050 |
Why?
|
Frozen Sections | 1 | 1998 | 11 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 1999 | 110 | 0.040 |
Why?
|
Tracheitis | 1 | 1997 | 1 | 0.040 |
Why?
|
Paraneoplastic Syndromes | 1 | 1997 | 6 | 0.040 |
Why?
|
Airway Obstruction | 1 | 1997 | 14 | 0.040 |
Why?
|
Pemphigus | 1 | 1997 | 14 | 0.040 |
Why?
|
Fluorocarbons | 1 | 1998 | 23 | 0.040 |
Why?
|
Pneumonia, Pneumococcal | 1 | 1998 | 27 | 0.040 |
Why?
|
Mice | 3 | 2009 | 9076 | 0.040 |
Why?
|
Pleurisy | 1 | 1997 | 1 | 0.040 |
Why?
|
Nevada | 1 | 1997 | 3 | 0.040 |
Why?
|
Pleural Diseases | 1 | 1997 | 7 | 0.040 |
Why?
|
Oregon | 1 | 1997 | 19 | 0.040 |
Why?
|
Chemistry, Physical | 1 | 1997 | 44 | 0.040 |
Why?
|
Occupational Diseases | 1 | 1999 | 240 | 0.040 |
Why?
|
Carcinogens | 1 | 1997 | 35 | 0.040 |
Why?
|
Receptor, ErbB-2 | 1 | 1997 | 48 | 0.040 |
Why?
|
Ki-67 Antigen | 1 | 1997 | 30 | 0.040 |
Why?
|
Chemical Phenomena | 1 | 1997 | 89 | 0.040 |
Why?
|
Carcinoma, Acinar Cell | 1 | 1996 | 2 | 0.040 |
Why?
|
Silver Staining | 1 | 1996 | 5 | 0.040 |
Why?
|
Tissue Fixation | 1 | 1996 | 19 | 0.040 |
Why?
|
Paraffin Embedding | 1 | 1996 | 13 | 0.040 |
Why?
|
Microscopy | 1 | 1997 | 68 | 0.040 |
Why?
|
Occupational Exposure | 1 | 1999 | 303 | 0.040 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2016 | 14 | 0.040 |
Why?
|
Forecasting | 1 | 1997 | 193 | 0.040 |
Why?
|
Tumor Virus Infections | 1 | 1996 | 40 | 0.040 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 1996 | 58 | 0.040 |
Why?
|
Herpesviridae Infections | 1 | 1996 | 32 | 0.040 |
Why?
|
Germinoma | 1 | 1995 | 2 | 0.040 |
Why?
|
Autoimmune Diseases | 1 | 1997 | 182 | 0.040 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 1996 | 69 | 0.040 |
Why?
|
Carcinoma, Papillary | 1 | 1996 | 34 | 0.040 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2016 | 50 | 0.040 |
Why?
|
ras Proteins | 1 | 2016 | 70 | 0.040 |
Why?
|
Testicular Neoplasms | 1 | 1995 | 25 | 0.040 |
Why?
|
Neoplastic Cells, Circulating | 1 | 1995 | 28 | 0.040 |
Why?
|
DNA Mutational Analysis | 1 | 2016 | 179 | 0.040 |
Why?
|
Heart Neoplasms | 1 | 1995 | 29 | 0.040 |
Why?
|
Respiration, Artificial | 1 | 1998 | 218 | 0.040 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2016 | 187 | 0.040 |
Why?
|
Thyroid Neoplasms | 1 | 1996 | 67 | 0.040 |
Why?
|
Survival Rate | 1 | 1997 | 656 | 0.030 |
Why?
|
Tissue Adhesions | 1 | 1994 | 24 | 0.030 |
Why?
|
Herpesvirus 4, Human | 1 | 1996 | 169 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 249 | 0.030 |
Why?
|
Lipoma | 1 | 1994 | 16 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 1997 | 1936 | 0.030 |
Why?
|
Soft Tissue Neoplasms | 1 | 1994 | 34 | 0.030 |
Why?
|
Acyclovir | 1 | 2014 | 20 | 0.030 |
Why?
|
Survival Analysis | 2 | 1992 | 473 | 0.030 |
Why?
|
Vulvar Neoplasms | 1 | 1993 | 9 | 0.030 |
Why?
|
Cocaine | 1 | 1994 | 74 | 0.030 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 1993 | 25 | 0.030 |
Why?
|
Neoplasm Invasiveness | 3 | 2003 | 199 | 0.030 |
Why?
|
Cell Line | 2 | 2009 | 1921 | 0.030 |
Why?
|
Peritoneum | 1 | 2011 | 30 | 0.030 |
Why?
|
Lymphocytes | 2 | 2003 | 170 | 0.030 |
Why?
|
Antiviral Agents | 1 | 2014 | 291 | 0.030 |
Why?
|
Lymph Nodes | 1 | 1991 | 187 | 0.020 |
Why?
|
Oscillometry | 1 | 2009 | 11 | 0.020 |
Why?
|
Microscopy, Phase-Contrast | 1 | 2009 | 15 | 0.020 |
Why?
|
Formoterol Fumarate | 1 | 2009 | 5 | 0.020 |
Why?
|
Inositol 1,4,5-Trisphosphate | 1 | 2009 | 28 | 0.020 |
Why?
|
Histamine | 1 | 2009 | 39 | 0.020 |
Why?
|
Respiratory Syncytial Virus, Human | 1 | 2009 | 20 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 1995 | 1049 | 0.020 |
Why?
|
Cytoplasmic Granules | 1 | 1989 | 55 | 0.020 |
Why?
|
HN Protein | 1 | 2009 | 56 | 0.020 |
Why?
|
Ryanodine Receptor Calcium Release Channel | 1 | 2009 | 48 | 0.020 |
Why?
|
Immunization | 1 | 2009 | 115 | 0.020 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2009 | 57 | 0.020 |
Why?
|
Bronchodilator Agents | 1 | 2009 | 52 | 0.020 |
Why?
|
Muscle, Smooth | 1 | 2009 | 84 | 0.020 |
Why?
|
Necrosis | 3 | 1997 | 115 | 0.020 |
Why?
|
Cell Nucleus | 1 | 1992 | 559 | 0.020 |
Why?
|
Muscle Contraction | 1 | 2009 | 160 | 0.020 |
Why?
|
Infant | 2 | 1994 | 1387 | 0.020 |
Why?
|
Mutation | 1 | 2016 | 2187 | 0.020 |
Why?
|
Calcium Signaling | 1 | 2009 | 150 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2009 | 453 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2009 | 814 | 0.020 |
Why?
|
Global Health | 1 | 1988 | 136 | 0.020 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2006 | 34 | 0.020 |
Why?
|
Substance-Related Disorders | 1 | 1994 | 606 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2011 | 884 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 2007 | 122 | 0.020 |
Why?
|
Cervix Uteri | 1 | 2006 | 56 | 0.020 |
Why?
|
Sex Factors | 1 | 1987 | 851 | 0.020 |
Why?
|
Gene Expression | 1 | 2007 | 753 | 0.020 |
Why?
|
Sex Chromosome Aberrations | 1 | 2003 | 1 | 0.020 |
Why?
|
Hybridization, Genetic | 1 | 2003 | 12 | 0.020 |
Why?
|
Genes, Viral | 1 | 2003 | 55 | 0.020 |
Why?
|
Chromosomes, Human, X | 1 | 2003 | 33 | 0.020 |
Why?
|
Vero Cells | 1 | 2003 | 78 | 0.020 |
Why?
|
Vaccinia | 1 | 2003 | 40 | 0.020 |
Why?
|
Immunocompetence | 1 | 2003 | 20 | 0.020 |
Why?
|
Age Factors | 1 | 1987 | 1410 | 0.020 |
Why?
|
Orthomyxoviridae Infections | 1 | 2003 | 71 | 0.020 |
Why?
|
Ultrasonography | 1 | 2005 | 387 | 0.020 |
Why?
|
Allelic Imbalance | 1 | 2002 | 7 | 0.010 |
Why?
|
Gene Amplification | 1 | 2002 | 22 | 0.010 |
Why?
|
Chromosome Deletion | 1 | 2002 | 32 | 0.010 |
Why?
|
Radiography | 1 | 2003 | 341 | 0.010 |
Why?
|
Chromosome Aberrations | 1 | 2002 | 60 | 0.010 |
Why?
|
Nylons | 1 | 1999 | 7 | 0.010 |
Why?
|
Lymphoid Tissue | 1 | 1999 | 47 | 0.010 |
Why?
|
Thyroglobulin | 1 | 1999 | 10 | 0.010 |
Why?
|
Triiodothyronine | 1 | 1999 | 27 | 0.010 |
Why?
|
Cytokines | 1 | 2003 | 816 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 1999 | 96 | 0.010 |
Why?
|
Air Pollutants, Occupational | 1 | 1999 | 76 | 0.010 |
Why?
|
Penicillin G | 1 | 1998 | 6 | 0.010 |
Why?
|
Macrophages | 1 | 2003 | 913 | 0.010 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 1997 | 46 | 0.010 |
Why?
|
Rats, Wistar | 1 | 1998 | 166 | 0.010 |
Why?
|
Hypoxia | 1 | 1997 | 73 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2003 | 2854 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 1996 | 198 | 0.010 |
Why?
|
Vena Cava, Inferior | 1 | 1995 | 26 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 1995 | 299 | 0.010 |
Why?
|
Skin | 1 | 1997 | 318 | 0.010 |
Why?
|
Buttocks | 1 | 1994 | 9 | 0.010 |
Why?
|
Lipomatosis | 1 | 1994 | 7 | 0.010 |
Why?
|
RNA, Viral | 1 | 1996 | 269 | 0.010 |
Why?
|
Facial Dermatoses | 1 | 1994 | 12 | 0.010 |
Why?
|
Heart Ventricles | 1 | 1995 | 166 | 0.010 |
Why?
|
Head and Neck Neoplasms | 1 | 1994 | 61 | 0.010 |
Why?
|
Hemorrhage | 1 | 1994 | 229 | 0.010 |
Why?
|
Survivors | 1 | 1992 | 139 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 1992 | 527 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1989 | 236 | 0.010 |
Why?
|
Staining and Labeling | 1 | 1989 | 123 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 1988 | 58 | 0.010 |
Why?
|